Release-Activity: A Long Way from Phenomenon to New Drugs
Author:
- 23 November 2012
- journal article
- new drugs
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 154 (1) , 54-58
Abstract
Multiple dilutions of the original substance release its peculiar activity referred to as “releaseactivity”. Although this activity originates from the initial substance, it does not depend on its negligible concentration in extreme dilutions. Thus, the terms “dose”, “ultralow dose”, and “homeopathic dose”, do not correctly describe the release-active solutions, since the concept of dose implies the presence of some part of the original substance in a dilution with its intrinsic therapeutic potency. The data are reported on the molecular and cellular mechanisms of the mode of action of the release-active agents, some of which being introduced into clinical practice.Keywords
This publication has 6 references indexed in Scilit:
- RETRACTED: Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in miceAntiviral Research, 2012
- Preclinical studied of general toxic properties of preparations containing ultralow doses of antibodies to endogenous regulators.Bulletin of Experimental Biology and Medicine, 2009
- Membrane and synaptic effects of anti-s-100 are prevented by the same antibodies in low concentrationsFrontiers in Bioscience-Landmark, 2003
- Age dependence of skin autofluorescenceBulletin of Experimental Biology and Medicine, 1999
- "High-dilution" experiments a delusionNature, 1988
- Human basophil degranulation triggered by very dilute antiserum against IgENature, 1988